Valneva Corp (VALN): Total Asset Value of Company

Graphic logo of Valneva Pharma (VALN)

Valneva SE (VALN) minimizes biotechnological risks by developing treatments for chikungunya and Lyme disease through strategic alliances. This chart illustrates that the asset's market value reaches 499.35. Business efficiency is based on European capacities with cold-chain logistics, ensuring high profitability. Meanwhile, Valneva SE (VALN) strictly adheres to environmental standards, implementing energy saving and safe biomaterial recycling at its plants.

Valneva SE (VALN) Company Total Assets: for the period 07/04/2022 - 10/28/2026

Comprehensive metric breakdowns and analytics for Valneva Pharma (VALN)

- price and consensus price forecast:
Share Price valneva.com|VALN - Price Target Chart
- market capitalization data:
Market Valuation Valneva Vaccines|VALN - Enterprise Value
- book capitalization data:
Accounting Value of a Share Valneva|VALN - Book Capitalization|Market Capitalization to Book Value Ratio valneva.com|VALN - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Valneva SE|VALN - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Valneva Vaccines|VALN - Company Aggregate Debts|Debts to Book Capitalization Valneva Vaccines|VALN - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Valneva
Fundamental valuation:VALN, valneva.com
Finished products of Valneva SE

Total assets represent the aggregate volume of company resources, calculated reverse-engineered via ROA to eliminate the time lags of standard reporting. This metric allows an investor to assess capital management efficiency and identify hidden leverage. By analyzing the total assets forecast, one can evaluate how the resource base of Valneva SE supports its status as a scientific leader in the development of unique vaccines.

Competitors of Valneva SE (VALN)

GILD (gilead.com) - Total Business Assets|Aggregate Company Assets cidara.com CDTX|Total Asset Value of Company Novavax Inc|CureVac Corp (CVAC) - Company Total Assets|Aggregate Asset Value Vir Corp (VIR)|Company Total Assets SIGA (SIGA Technologies, Inc.)|emergentbiosolutions.com - Company Total Assets|Aggregate Company Assets Atea Pharmaceuticals, Inc. (AVIR)|IVVD: Aggregate Asset Value|ENTA (Enanta) - Aggregate Company Assets|Inovio Pharma (INO) - Cumulative Company Assets|HLVX (HilleVax, Inc.) - Company Total Assets|Company Total Assets kalaristx.com (KLRS)|Dyadic International (DYAI) - Cumulative Company Assets|Aggregate Asset Value nanoviricides.com NNVC|Cumulative Company Assets Talphera Corp TLPH|Aggregate Company Assets Cocrystal Pharma Corp COCP|Company Total Assets TRAW (Traws Therapeutics)|DWTX: Company Total Asset Base|Aggregate Company Assets Qualigen Therapeutics, Inc. QLGN|Aggregate Asset Value AlloVir|VBIV (VBI Vaccines, Inc.) - Cumulative Company Assets|Company Total Assets VIRI|VXRT (Vaxart, Inc.) - Aggregate Company Assets